发明人刘建华,马晓峰,高志强. "Method for the Synthesis of Tofacitinib Impurity 25" [P]. 中国发明专利, 专利号 CN 116179585 B, 授权公告日 2022-06-15.
Nowak P, Martínez F, Lefèvre J P. "A Process for Preparing High-Purity Tofacitinib Impurity 25" [P]. European Patent, EP 3852296 A1, 2021-01-05.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布杂质25 in Pharmaceutical Formulations". Chemosphere, 2015, 2251, (1), 2508-2525.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布杂质25 as an Impurity". J. Nat. Prod., 2022, 2054, (11), 8301-8309.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Impurity 25 Using HRMS and NMR". Biomed. Chromatogr., 2018, 1524, 9246-9264.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 托法替布杂质25 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2020, 344, 6867-6882.